KR20070027649A - 안구내의 상의 질의 개선 방법 - Google Patents

안구내의 상의 질의 개선 방법 Download PDF

Info

Publication number
KR20070027649A
KR20070027649A KR1020067027745A KR20067027745A KR20070027649A KR 20070027649 A KR20070027649 A KR 20070027649A KR 1020067027745 A KR1020067027745 A KR 1020067027745A KR 20067027745 A KR20067027745 A KR 20067027745A KR 20070027649 A KR20070027649 A KR 20070027649A
Authority
KR
South Korea
Prior art keywords
lutein
zeaxanthin
body weight
quality
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020067027745A
Other languages
English (en)
Korean (ko)
Inventor
존 바버
Original Assignee
디에스엠 아이피 어셋츠 비.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 디에스엠 아이피 어셋츠 비.브이. filed Critical 디에스엠 아이피 어셋츠 비.브이.
Publication of KR20070027649A publication Critical patent/KR20070027649A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Eye Examination Apparatus (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
KR1020067027745A 2004-06-29 2005-06-08 안구내의 상의 질의 개선 방법 Ceased KR20070027649A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04015189 2004-06-29
EP04015189.6 2004-06-29

Publications (1)

Publication Number Publication Date
KR20070027649A true KR20070027649A (ko) 2007-03-09

Family

ID=35782481

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067027745A Ceased KR20070027649A (ko) 2004-06-29 2005-06-08 안구내의 상의 질의 개선 방법

Country Status (9)

Country Link
US (2) US20080045605A1 (enExample)
EP (1) EP1761254B1 (enExample)
JP (1) JP5074184B2 (enExample)
KR (1) KR20070027649A (enExample)
CN (1) CN101094666B (enExample)
AT (1) ATE441406T1 (enExample)
DE (1) DE602005016405D1 (enExample)
ES (1) ES2331083T3 (enExample)
WO (1) WO2006002735A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006084687A1 (en) * 2005-02-11 2006-08-17 Dsm Ip Assets B.V. Use of zeaxanthin for the treatment of diseases of the peripheral retina
AT503329A1 (de) 2006-03-02 2007-09-15 Omnica Gmbh Verfahren zur herstellung einer zusammensetzung, welche zumindest ein xantophyll enthält

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218436B1 (en) * 1993-06-28 2001-04-17 The Howard Foundation Pharmaceutically active carotenoids
US5382714A (en) * 1994-03-17 1995-01-17 The Catholic University Of America Process for isolation, purification, and recrystallization of lutein from saponified marigold oleoresin and uses thereof
US5827652A (en) * 1995-10-31 1998-10-27 Applied Food Biotechnology, Inc. Zeaxanthin formulations for human ingestion
FR2749758B1 (fr) * 1996-06-12 1998-08-07 Oenobiol Sa Lab Composition a activite bronzante et photoprotectrice et ses applications esthetiques
WO1997048388A1 (en) * 1996-06-17 1997-12-24 The Board Of Trustees Of The University Of Illinois Method of retarding and ameliorating central nervous system and eye damage
US6075058A (en) * 1998-12-12 2000-06-13 Tufts University Compositions for increased bioavailability of carotenoids
US6712466B2 (en) * 2001-10-25 2004-03-30 Ophthonix, Inc. Eyeglass manufacturing method using variable index layer
US20050032914A1 (en) * 2002-01-30 2005-02-10 Felix Barker Lutein/zeaxanthin for glare protection
CN1481804A (zh) * 2002-12-17 2004-03-17 无锡杰西医药科技有限公司 防治白内障、黄斑变性等眼病的配方及其使用方法

Also Published As

Publication number Publication date
JP2008505137A (ja) 2008-02-21
DE602005016405D1 (de) 2009-10-15
US20080045605A1 (en) 2008-02-21
JP5074184B2 (ja) 2012-11-14
ES2331083T3 (es) 2009-12-21
EP1761254B1 (en) 2009-09-02
CN101094666B (zh) 2010-09-29
EP1761254A1 (en) 2007-03-14
CN101094666A (zh) 2007-12-26
WO2006002735A1 (en) 2006-01-12
ATE441406T1 (de) 2009-09-15
US20110172313A1 (en) 2011-07-14

Similar Documents

Publication Publication Date Title
TR201809213T4 (tr) Kamaşma yetersizliğinin iyileştirilmesine yönelik yöntem.
US20130045940A1 (en) Composition comprising as active ingredient l-carnitine in combination with a solar filter, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
US20230321023A1 (en) Application of regulation of eye sclera lipid metabolism to inhibit myopia
FR3034018A1 (fr) Composition ophtalmique nutraceutique pour la sante oculaire
US7691420B2 (en) Compositions for the treatment and prevention of diabetes mellitus
Kono et al. Effect of multiple dietary supplement containing lutein, astaxanthin, cyanidin-3-glucoside, and DHA on accommodative ability
KR20180118951A (ko) 안구 질환 예방 또는 개선용 건강기능식품 조성물
US20070275098A1 (en) Formulation and methodology for the treatment for eye impairment symptoms
US20110172313A1 (en) Image quality in the eye
JP2003026589A (ja) 眼病予防および視覚改善剤
JP5848042B2 (ja) 眼疲労抑制組成物及びそれを含む飲食品
WO2002094253A1 (en) Agents for relieving eye controlling function error
WO2021107106A1 (ja) 経口組成物
EP4003341A1 (en) Compositions and methods for treatment of presbyopia
ES2993253T3 (en) Composition of a dietary supplement and/or a nutritional additive for food, a unitary dosage form of said composition, and their use for improvement of the quality of visual performance including contrast sensitivity in persons in need of such an improvement, including persons suffering from at least one eye disease, particularly vitreous floaters
US20080167384A1 (en) Use of Zeaxanthin For the Treatment of Diseases of the Peripheral Retina
CN114096165A (zh) 一种缓解视疲劳的可食用组合物
HK40068445A (en) Composition of a dietary supplement and/or a nutritional additive for food, a unitary dosage form of said composition, and their use for improvement of the quality of visual performance including contrast sensitivity in persons in need of such an improvement, including persons suffering from at least one eye disease, particularly vitreous floaters
Marcolina Diet and Macular Degeneration: Eye-Opening Potential

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20061228

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20100608

Comment text: Request for Examination of Application

PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20111221

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20121127

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20111221

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I